Yestino - The Signal ยท China Abogenhttps://yestino.com/entities/china-abogen-e8863aEvery event involving China AbogenenNovartis is licensing an mRNA autoimmune therapy from China's Abogen for up to $7.8 billionhttps://yestino.com/events/novartis-is-licensing-an-mrna-autoimmune-therapy-from-china-16d84dhttps://yestino.com/events/novartis-is-licensing-an-mrna-autoimmune-therapy-from-china-16d84dFri, 02 Oct 2026 13:40:38 GMTThe Swiss drugmaker will pay $575 million upfront to license ABO2203, with up to $7.2 billion more tied to milestones Sources: Quartz